Ping An Healthcare and Technology Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Dou Li

İcra Kurulu Başkanı

CN¥3.5m

Toplam tazminat

CEO maaş yüzdesi	18.8%
CEO görev süresi	1.2yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	3yrs
Yönetim Kurulu ortalama görev süresi	1.8yrs

Son yönetim güncellemeleri

Recent updates

Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Nov 17

Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Sep 27

Ping An Healthcare and Technology Company Limited (HKG:1833) Shares Could Be 49% Below Their Intrinsic Value Estimate

Sep 20

Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Not Quite Adding Up

Jul 17

Revenues Not Telling The Story For Ping An Healthcare and Technology Company Limited (HKG:1833)

Apr 17

Ping An Healthcare and Technology (HKG:1833) Is In A Strong Position To Grow Its Business

Mar 20

Calculating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Jan 12

Getting In Cheap On Ping An Healthcare and Technology Company Limited (HKG:1833) Is Unlikely

Dec 22

We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely

Sep 27

A Look At The Intrinsic Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Sep 10

When Should You Buy Ping An Healthcare and Technology Company Limited (HKG:1833)?

Aug 02

Here's Why We're Not Too Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Situation

Jun 26

Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Could Signal Some Risk

Jun 07

Is There An Opportunity With Ping An Healthcare and Technology Company Limited's (HKG:1833) 46% Undervaluation?

Apr 04

Should You Think About Buying Ping An Healthcare and Technology Company Limited (HKG:1833) Now?

Feb 16

We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth

Jan 23

A Look At The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Jan 02

Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Oct 11

Estimating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Sep 14

Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Jun 22

We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely

Mar 01

We're Not Very Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Rate

Nov 13

Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?

Oct 18

Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Aug 05

Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?

Jul 10

We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth

Apr 04

If You Had Bought Ping An Healthcare and Technology (HKG:1833) Shares A Year Ago You'd Have Earned 47% Returns

Feb 28

Are Institutions Heavily Invested In Ping An Healthcare and Technology Company Limited's (HKG:1833) Shares?

Jan 24

We Think Ping An Healthcare and Technology (HKG:1833) Can Easily Afford To Drive Business Growth

Dec 29

Does This Valuation Of Ping An Healthcare and Technology Company Limited (HKG:1833) Imply Investors Are Overpaying?

Dec 03

CEO Tazminat Analizi

Dou Li'un ücretlendirmesi Ping An Healthcare and Technology'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	-CN¥21m
Mar 31 2024	n/a	n/a	-CN¥172m
Dec 31 2023	CN¥4m	CN¥664k	-CN¥323m

Tazminat ve Piyasa: Dou 'ın toplam tazminatı ($USD 484.09K ) Hong Kong pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 479.54K ).

Tazminat ve Kazançlar: Dou şirketinin tazminatını şirket performansıyla karşılaştırmak için yeterli veri yok.

CEO

Dou Li (48 yo)

1.2yrs

Görev süresi

CN¥3,533,272

Tazminat

Mr. Dou Li serves as Executive Director, Chairman and Chief Executive Officer from October 18, 2023 and he served as Non-Executive Director of Ping An Healthcare and Technology Company Limited from August...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Dou Li	CEO & Executive Chairman	1.2yrs	CN¥3.53m	Veri yok
Jun Wu	President & Executive Director	3.2yrs	CN¥10.09m	Veri yok
Luoqi Zang	Senior VP & CFO	2.8yrs	Veri yok	Veri yok
Cheng Liu	Senior VP	4.6yrs	Veri yok	Veri yok

3.0yrs

Ortalama Görev Süresi

49yo

Ortalama Yaş

Deneyimli Yönetim: 1833 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Dou Li	CEO & Executive Chairman	1.3yrs	CN¥3.53m	Veri yok
Jun Wu	President & Executive Director	1.8yrs	CN¥10.09m	Veri yok
Wing Kin Chow	Independent Non-Executive Director	6.6yrs	CN¥441.00k	Veri yok
Yunwei Tang	Independent Non-Executive Director	6.6yrs	CN¥441.00k	Veri yok
Tianyong Guo	Independent Non-Executive Director	6.6yrs	CN¥441.00k	Veri yok
Fangfang Cai	Non-Executive Director	less than a year	Veri yok	Veri yok
Michael Guo	Non-Executive Director	less than a year	Veri yok	Veri yok
Ziyang Zhu	Non-Executive Director	3yrs	Veri yok	Veri yok
Xin Fu	Non Executive Director	1.8yrs	Veri yok	Veri yok

1.8yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 1833 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 1.8 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.

Şirket Analizi ve Finansal Veri Durumu

Veri	Son Güncelleme (UTC saati)
Şirket Analizi	2024/12/20 04:17
Gün Sonu Hisse Fiyatı	2024/12/20 00:00
Kazançlar	2024/06/30
Yıllık Kazançlar	2023/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

Paket	Veri	Zaman Çerçevesi	Örnek ABD Kaynağı ^*
Şirket Finansalları	10 yıl	Gelir tablosu Nakit akış tablosu Bilanço	SEC Form 10-K SEC Form 10-Q
Analist Konsensüs Tahminleri	+3 yıl	Finansal tahminler Analist fiyat hedefleri	Analist Araştırma Raporları Blue Matrix
Piyasa Fiyatları	30 yıl	Hisse senedi fiyatları Temettüler, Bölünmeler ve Eylemler	ICE Piyasa Verileri SEC Form S-1
Sahiplik	10 yıl	En büyük hissedarlar İçeriden öğrenenlerin ticareti	SEC Form 4 SEC Form 13D
Yönetim	10 yıl	Liderlik ekibi Yönetim Kurulu	SEC Form 10-K SEC Form DEF 14A
Önemli Gelişmeler	10 yıl	Şirket duyuruları	SEC Form 8-K

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Buradan daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntıları Github sayfamızda mevcuttur, ayrıca raporlarımızın nasıl kullanılacağına dair kılavuzlarımız ve Youtube'da eğitimlerimiz bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları 'da mevcuttur.

Analist Kaynakları

Ping An Healthcare and Technology Company Limited 25 Bu analistlerden 13, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

Analist	Kurum
Xiaomeng Zhuang	BofA Global Research
Shun Kei Law	CCB International Securities Limited
Hazim Bahari	CFRA Equity Research

Ping An Healthcare and Technology Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

President & Executive Director exercised options and sold HK$1.4m worth of stock

Ping An Healthcare and Technology Company Limited, Annual General Meeting, Apr 22, 2024

Ping An Healthcare and Technology Company Limited Announces Management Changes

Ping an Healthcare and Technology Company Limited Announces Board Changes

Ping an Healthcare and Technology Appoints Mr. Li Dou as Non-Executive Director

Less than half of directors are independent

Recent updates

President & Executive Director exercised options and sold HK$1.4m worth of stock

New major risk - Share price stability

Ping An Healthcare and Technology Company Limited Approves Special Dividend

Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected

Ping An Healthcare and Technology Company Limited Proposes Special Dividend, Payable no later than 24 January 2025

Ping An Healthcare and Technology Company Limited Proposes Special Dividend, Payable no later than 24 January 2025

Ping An Healthcare and Technology Company Limited (HKG:1833) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected

Ping An Healthcare and Technology Company Limited (HKG:1833) Shares Could Be 49% Below Their Intrinsic Value Estimate

First half 2024 earnings released: EPS: CN¥0.052 (vs CN¥0.23 loss in 1H 2023)

Forecast breakeven date moved forward to 2024

Ping An Healthcare and Technology Company Limited to Report First Half, 2024 Results on Aug 20, 2024

Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Not Quite Adding Up

Forecast to breakeven in 2025

Forecast breakeven date pushed back to 2026

Forecast breakeven date moved forward to 2025

Revenues Not Telling The Story For Ping An Healthcare and Technology Company Limited (HKG:1833)

Ping An Healthcare and Technology Company Limited, Annual General Meeting, Apr 22, 2024

Consensus EPS estimates fall by 17%

Ping An Healthcare and Technology Company Limited Announces Management Changes

Ping An Healthcare and Technology (HKG:1833) Is In A Strong Position To Grow Its Business

No longer forecast to breakeven

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 21% undervalued after recent price drop

Calculating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Ping An Healthcare and Technology Company Limited to Report Fiscal Year 2023 Results on Mar 19, 2024

Getting In Cheap On Ping An Healthcare and Technology Company Limited (HKG:1833) Is Unlikely

Ping an Healthcare and Technology Company Limited Announces Board Changes

We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely

A Look At The Intrinsic Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

First half 2023 earnings released: CN¥0.23 loss per share (vs CN¥0.43 loss in 1H 2022)

Ping an Healthcare and Technology Appoints Mr. Li Dou as Non-Executive Director

When Should You Buy Ping An Healthcare and Technology Company Limited (HKG:1833)?

Ping An Healthcare and Technology Company Limited to Report Q2, 2023 Results on Aug 24, 2023

Here's Why We're Not Too Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Situation

Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Could Signal Some Risk

Is There An Opportunity With Ping An Healthcare and Technology Company Limited's (HKG:1833) 46% Undervaluation?

Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Forecast to breakeven in 2025

Should You Think About Buying Ping An Healthcare and Technology Company Limited (HKG:1833) Now?

Ping An Healthcare and Technology Company Limited to Report Fiscal Year 2022 Results on Feb 13, 2023

We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth

A Look At The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

Less than half of directors are independent

Ping An Healthcare and Technology Company Limited (SEHK:1833) entered into the equity transfer agreements to acquire Ping An International Smart City Technology Co., Ltd. from Scientia Technologies Limited for $96.8646 million.

Ping An Healthcare and Technology Company Limited (SEHK:1833) entered into the equity transfer agreements to acquire Ping An International Smart City Technology Co., Ltd. from Scientia Technologies Limited for $96.8646 million.

Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Estimating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)

First half 2022 earnings released: CN¥0.39 loss per share (vs CN¥0.80 loss in 1H 2021)

Ping An Healthcare and Technology Company Limited to Report First Half, 2022 Results on Aug 18, 2022

Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Less than half of directors are independent

Consensus EPS estimates fall by 11%

No longer forecast to breakeven

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely

Forecast to breakeven in 2024

Ping An Healthcare and Technology Company Limited (SEHK:1833) commences an Equity Buyback Plan for 114,729,420 shares, representing 10% of its issued share capital, under the authorization approved on April 21, 2021.

Less than half of directors are independent

We're Not Very Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Rate

Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?

Joint Company Secretary Chun Chen has left the company

First half 2021 earnings released: CN¥0.80 loss per share (vs CN¥0.21 loss in 1H 2020)

Non-Executive Director Bo Yao has left the company

Non-Executive Director Fangfang Cai has left the company

Independent Non-Executive Director Xin Liu has left the company

Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth

Consensus forecasts updated

Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?

We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth